10x Genomics (TXG) Accumulated Expenses (2018 - 2026)

10x Genomics' Accumulated Expenses history runs 9 years deep, the most recent figure standing at $21.5 million for Q1 2026.

• In Q1 2026, Accumulated Expenses fell 52.72% year-over-year to $21.5 million; the TTM figure through Mar 2026 stood at $21.5 million (down 52.72% YoY), while the FY2025 annual figure was $42.5 million, up 3.24% from the prior year.
• Accumulated Expenses came in at $21.5 million for Q1 2026 at 10x Genomics, down from $42.5 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $62.0 million in Q3 2022 to a low of $20.7 million in Q1 2024.
• A 5-year average of $37.9 million and a median of $39.1 million in 2025 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses tumbled 56.38% in 2024 and jumped 120.04% in 2025, its largest moves.
• 10x Genomics' Accumulated Expenses stood at $59.8 million in 2022, then slumped by 49.64% to $30.1 million in 2023, then soared by 36.74% to $41.2 million in 2024, then climbed by 3.24% to $42.5 million in 2025, then sank by 49.4% to $21.5 million in 2026.
• According to Business Quant data, Accumulated Expenses over the past three periods registered $21.5 million, $42.5 million, and $35.8 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison